Table VI.

Associations between lncRNA signature and ESCC patients' clinicopathological characteristics.

Comparisons	Upregulated	Downregulated
Sex (male vs. female)		C20orf166-AS1, UG0898H09, PART1
Race (Caucasian vs. Asian)	ALOX12P2, DUSP5P1	PART1, LINC00341, LINC00982, DIRC3
Tumor grade	PTGES2-AS1, LINC01588, BTN2A3P,	PSMG3-AS1, CMAHP, LINC00472, LINC01105,
(GIII–IV vs. GI–II)	LOC728743, RPLPOP2, LINC00346	SBF1P1, DIRC3, SMIM10L2A, ZNF300P1, TP73-AS1
TNM stage (T3 + T4 vs. T1 + T2)	RPLP0P2, DDX12P, PVT1, HCP5	LINC00472, LOC148696, SMIM10L2A, ZNF300P1, SMIM10L2B, HAND2-AS1
Lymphatic metastasis (yes vs. no)	PTGES2-AS1, FOXD2-AS1, TCAM1P, LINC00176	DIRC3, LINC00982, LOC148696, SBF1P1

ESCC, esophageal squamous cell carcinoma; lncRNA, long non-coding RNA.